AUTL vs TECH · rev $10.1M vs P/E 65, rev $1.22B
Autolus Therapeutics Ltd (AUTL) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AUTL revenue for 2024-12-31 was $10.1M. Net income was -$220.7M. Revenue was up 496.0% from 2023-12-31 to 2024-12-31. AUTL currently screens at market cap $614.8M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AUTL currently screens at market cap $614.8M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AUTL and TECH stock pages for the full models.
Not investment advice.